Search research articles
Contact Us
Filters
Showing results (21-30 of 127) with videos related to
Page
of 13
Sort By:
Panminerva Medica
|
September 22, 2020
Old and new generation proteasome inhibitors in multiple myeloma
Vittorio Montefusco, Alberto Mussetti, Maria Q Salas, et al.
Panminerva Medica
|
September 21, 2020
Current and future perspectives of maintenance therapy in multiple myeloma
Chandramouli Nagarajan, Melinda S Tan, Yunxin Chen, et al.
Hematology Reports
|
October 12, 2020
How we manage smoldering multiple myeloma
Alessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
Panminerva Medica
|
September 21, 2020
BCMA-targeting approaches for treatment of multiple myeloma
Yunxin Chen, Chandramouli Nagarajan, Melinda S Tan, et al.
Journal of Hematology & Oncology
|
September 22, 2020
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Andrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, et al.
Hematology Reports
|
May 28, 2024
Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia
Samir Mouhssine, Nawar Maher, Sreekar Kogila, et al.
International Journal of Molecular Sciences
|
March 6, 2021
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia
Massimo Martino, Caterina Alati, Filippo Antonio Canale, et al.
Panminerva Medica
|
September 21, 2020
Monoclonal antibodies in multiple myeloma
Federico Vozella, Francesca Fazio, Gianfranco Lapietra, et al.
Minerva Medica
|
September 21, 2020
Enasidenib and ivosidenib in AML
Maria Paola Martelli, Giovanni Martino, Valeria Cardinali, et al.
Hematology Reports
|
October 12, 2020
Treatment free remission in chronic myeloid leukemia: Lights and shadows
Matteo Molica, Nelida I Noguera, Malgorzata Monika Trawinska, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 127) with videos related to
Sort By:
Page
of 13
Panminerva Medica
|
September 22, 2020
Old and new generation proteasome inhibitors in multiple myeloma
Vittorio Montefusco, Alberto Mussetti, Maria Q Salas, et al.
Panminerva Medica
|
September 21, 2020
Current and future perspectives of maintenance therapy in multiple myeloma
Chandramouli Nagarajan, Melinda S Tan, Yunxin Chen, et al.
Hematology Reports
|
October 12, 2020
How we manage smoldering multiple myeloma
Alessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
Panminerva Medica
|
September 21, 2020
BCMA-targeting approaches for treatment of multiple myeloma
Yunxin Chen, Chandramouli Nagarajan, Melinda S Tan, et al.
Journal of Hematology & Oncology
|
September 22, 2020
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
Andrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, et al.
Hematology Reports
|
May 28, 2024
Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia
Samir Mouhssine, Nawar Maher, Sreekar Kogila, et al.
International Journal of Molecular Sciences
|
March 6, 2021
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic Leukemia
Massimo Martino, Caterina Alati, Filippo Antonio Canale, et al.
Panminerva Medica
|
September 21, 2020
Monoclonal antibodies in multiple myeloma
Federico Vozella, Francesca Fazio, Gianfranco Lapietra, et al.
Minerva Medica
|
September 21, 2020
Enasidenib and ivosidenib in AML
Maria Paola Martelli, Giovanni Martino, Valeria Cardinali, et al.
Hematology Reports
|
October 12, 2020
Treatment free remission in chronic myeloid leukemia: Lights and shadows
Matteo Molica, Nelida I Noguera, Malgorzata Monika Trawinska, et al.
Page
of 13